HKD 8.99
(2.63%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 711.8 Million CNY | -17.47% |
2022 | 862.5 Million CNY | 25.38% |
2021 | 687.9 Million CNY | 21.61% |
2020 | 565.66 Million CNY | -51.71% |
2019 | 1.17 Billion CNY | 24.35% |
2018 | 941.94 Million CNY | 77.53% |
2017 | 530.57 Million CNY | 0.0% |
2012 | 96.36 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 246.08 Million CNY | 130.76% |
2024 Q2 | 246.08 Million CNY | 0.0% |
2023 Q4 | -800.1 Million CNY | -554.63% |
2023 FY | 711.8 Million CNY | -17.47% |
2023 Q1 | 179.42 Million CNY | 58.61% |
2023 Q2 | 179.42 Million CNY | 0.0% |
2023 Q3 | 175.99 Million CNY | -1.92% |
2022 Q1 | 190.04 Million CNY | 126.61% |
2022 FY | 862.5 Million CNY | 25.38% |
2022 Q4 | 113.12 Million CNY | 0.0% |
2022 Q3 | 113.12 Million CNY | -40.47% |
2022 Q2 | 190.04 Million CNY | 0.0% |
2021 Q3 | 83.86 Million CNY | 155.68% |
2021 FY | 687.9 Million CNY | 21.61% |
2021 Q1 | 32.8 Million CNY | -77.81% |
2021 Q2 | 32.8 Million CNY | 0.0% |
2021 Q4 | 83.86 Million CNY | 0.0% |
2020 Q4 | 147.8 Million CNY | 0.0% |
2020 FY | 565.66 Million CNY | -51.71% |
2020 Q1 | 152.14 Million CNY | -46.99% |
2020 Q2 | 152.14 Million CNY | 0.0% |
2020 Q3 | 147.8 Million CNY | -2.85% |
2019 Q2 | 290.65 Million CNY | 0.0% |
2019 Q1 | 290.65 Million CNY | 0.0% |
2019 Q4 | 287.02 Million CNY | 0.0% |
2019 FY | 1.17 Billion CNY | 24.35% |
2019 Q3 | 287.02 Million CNY | -1.25% |
2018 FY | 941.94 Million CNY | 77.53% |
2017 FY | 530.57 Million CNY | 0.0% |
2013 Q1 | 50.18 Million CNY | 335.03% |
2013 Q2 | 10.71 Million CNY | -78.65% |
2013 Q3 | -181 Thousand CNY | -101.69% |
2012 Q1 | 53.3 Million CNY | 0.0% |
2012 Q2 | 50.71 Million CNY | -4.86% |
2012 Q3 | 1.68 Million CNY | -96.68% |
2012 Q4 | -21.35 Million CNY | -1367.93% |
2012 FY | 96.36 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 67.76 Million HKD | -950.351% |
CK Life Sciences Int'l., (Holdings) Inc. | 897.95 Million HKD | 20.731% |